Paper37077288
Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria.
Sagong HY and 8 others. Med Chem Res, 2022. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria. Papers, record 37077288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37077288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI118874 | NIAID NIH HHS | United States | R01AI118874 | PubMed and NIH |
Source NIH RePORTER
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17644596 | A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM. | J Bacteriol | 2007 | https://conductscience.org/library/papers/17644596 | PubMed |
| 2 | 17024474 | The prokaryotic cytoskeleton: a putative target for inhibitors and antibiotics? | Appl Microbiol Biotechnol | 2006 | https://conductscience.org/library/papers/17024474 | PubMed |
| 3 | 21823588 | Chemical-biological studies of subcellular organization in bacteria. | Biochemistry | 2011 | https://conductscience.org/library/papers/21823588 | PubMed |
| 4 | 21993484 | In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex. | Int J Antimicrob Agents | 2012 | https://conductscience.org/library/papers/21993484 | PubMed |
| 5 | 20381346 | Synthesis and evaluation of a series of C5'-substituted duocarmycin SA analogs. | Bioorg Med Chem Lett | 2010 | https://conductscience.org/library/papers/20381346 | PubMed |
| 6 | 17213642 | Structure-activity relationship study of the bacterial actin-like protein MreB inhibitors: effects of substitution of benzyl group in S-benzylisothiourea. | Biosci Biotechnol Biochem | 2007 | https://conductscience.org/library/papers/17213642 | PubMed |
| 7 | 20023035 | MreB drives de novo rod morphogenesis in Caulobacter crescentus via remodeling of the cell wall. | J Bacteriol | 2010 | https://conductscience.org/library/papers/20023035 | PubMed |
| 8 | 26548775 | Bacterial cytoskeleton and implications for new antibiotic targets. | J Drug Target | 2016 | https://conductscience.org/library/papers/26548775 | PubMed |
| 9 | 16391237 | Actin homolog MreB and RNA polymerase interact and are both required for chromosome segregation in Escherichia coli. | Genes Dev | 2006 | https://conductscience.org/library/papers/16391237 | PubMed |
| 10 | 22154164 | MreB: pilot or passenger of cell wall synthesis? | Trends Microbiol | 2012 | https://conductscience.org/library/papers/22154164 | PubMed |
| 11 | 27427089 | Antibacterial, cyto and genotoxic activities of A22 compound ((S-3, 4 -dichlorobenzyl) isothiourea hydrochloride). | Microb Pathog | 2016 | https://conductscience.org/library/papers/27427089 | PubMed |
| 12 | 14982627 | MreB, the cell shape-determining bacterial actin homologue, co-ordinates cell wall morphogenesis in Caulobacter crescentus. | Mol Microbiol | 2004 | https://conductscience.org/library/papers/14982627 | PubMed |
| 13 | 24603761 | The actin homologue MreB organizes the bacterial cell membrane. | Nat Commun | 2014 | https://conductscience.org/library/papers/24603761 | PubMed |
| 14 | 23756461 | Direct interaction of FtsZ and MreB is required for septum synthesis and cell division in Escherichia coli. | EMBO J | 2013 | https://conductscience.org/library/papers/23756461 | PubMed |
| 15 | 15564663 | Structure-activity relationship of S-benzylisothiourea derivatives to induce spherical cells in Escherichia coli. | Biosci Biotechnol Biochem | 2004 | https://conductscience.org/library/papers/15564663 | PubMed |
| 16 | 35625337 | TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/35625337 | PubMed |
| 17 | 15016371 | Bacterial mitotic machineries. | Cell | 2004 | https://conductscience.org/library/papers/15016371 | PubMed |
| 18 | 15707892 | MreB actin-mediated segregation of a specific region of a bacterial chromosome. | Cell | 2005 | https://conductscience.org/library/papers/15707892 | PubMed |
| 19 | 25784047 | Bacterial actin and tubulin homologs in cell growth and division. | Curr Biol | 2015 | https://conductscience.org/library/papers/25784047 | PubMed |
| 20 | 23473681 | Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA. | Bioorg Med Chem Lett | 2013 | https://conductscience.org/library/papers/23473681 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889336 | Bacterial actin MreB as a new antibiotic target. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42889336 | PubMed |
| 42859226 | Antibiotic-producing microorganisms: taxonomic diversity, screening strategies, and emerging and underexploited antibacterial targets. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42859226 | PubMed |
| 41900076 | Tetrahydrocarbazole as a Versatile Scaffold in Drug Discovery: A Cross-Target SAR Analysis and Design Paradigms. | Molecules | 2026 | https://conductscience.org/library/papers/41900076 | PubMed |
| 40847400 | MreB: unraveling the molecular mechanisms of bacterial shape, division, and environmental adaptation. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40847400 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37077288
GET https://conductscience.org/api/papers/v1/37077288/references?page=2